Sinem Namdaroğlu
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 22
- Hematopoietic Stem Cell Transplantation 14
- Acute Myeloid Leukemia Research 3
- Platelet Disorders and Treatments 2
-
- COVID-19 Clinical Research Studies 7
- Co-authors
- Fevzi Altuntaş (23 shared papers)Serdal Korkmaz (18 shared papers)Mehmet Sinan Dal (19 shared papers)İlhami Berber (10 shared papers)Tuba Hacıbekiroğlu (7 shared papers)Mehmet Ali Erkurt (15 shared papers)Burhan Turgut (7 shared papers)Tuğçe Nur Yiğenoğlu (12 shared papers)
In The Last Decade
Sinem Namdaroğlu
30 papers receiving 375 citations
Peers
Comparison fields: 5 of 37
- Infectious Diseases 203
- Hematology 105
- Oncology 105
- Genetics 23
- Immunology 23
Countries citing papers authored by Sinem Namdaroğlu
This map shows the geographic impact of Sinem Namdaroğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinem Namdaroğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinem Namdaroğlu more than expected).
Fields of papers citing papers by Sinem Namdaroğlu
This network shows the impact of papers produced by Sinem Namdaroğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sinem Namdaroğlu. The network helps show where Sinem Namdaroğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Sinem Namdaroğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 99 | |
| 2 | 2020 | 53 | |
| 3 | 2020 | 34 | |
| 4 | 2020 | 28 | |
| 5 | 2020 | 26 | |
| 6 | 2016 | 19 | |
| 7 | 2013 | 16 | |
| 8 | 2017 | 15 | |
| 9 | 2021 | 15 | |
| 10 | 2019 | 12 | |
| 11 | 2021 | 9 | |
| 12 | 2018 | 8 | |
| 13 | 2019 | 8 | |
| 14 | 2021 | 8 | |
| 15 | 2017 | 6 | |
| 16 | 2017 | 6 | |
| 17 | 2018 | 5 | |
| 18 | 2021 | 4 | |
| 19 | 2014 | 3 | |
| 20 | 2019 | 3 |
About Sinem Namdaroğlu
Sinem Namdaroğlu is a scholar working on Hematology, Infectious Diseases, Genetics, Oncology and Pathology and Forensic Medicine, having authored 41 papers that have together received 392 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (14 papers), COVID-19 Clinical Research Studies (7 papers), COVID-19 and healthcare impacts (4 papers), Acute Myeloid Leukemia Research (3 papers), Platelet Disorders and Treatments (2 papers), Complement system in diseases (2 papers), Histiocytic Disorders and Treatments (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Infectious Diseases (203 citations), Hematology (105 citations), Oncology (105 citations), Genetics (23 citations) and Immunology (23 citations). Sinem Namdaroğlu has collaborated with scholars based in Türkiye and Cyprus. Frequent co-authors include Fevzi Altuntaş, Serdal Korkmaz, Mehmet Sinan Dal, İlhami Berber, Tuba Hacıbekiroğlu, Mehmet Ali Erkurt, Burhan Turgut, Tuğçe Nur Yiğenoğlu, Abdulkadir Baştürk and Semih Başçı. Their work appears in journals such as Journal of Clinical Medicine, Blood, Internal and Emergency Medicine, Journal of Clinical Apheresis and Geriatrics and gerontology international.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.